spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online September 19, 2007
doi: 10.1242/10.1242/jcs.007872


Journal of Cell Science 120, 3352-3361 (2007)
Published by The Company of Biologists 2007
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clément, N.
Right arrow Articles by Limon, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clément, N.
Right arrow Articles by Limon, I.

Notch3 and IL-1beta exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-{kappa}B drives crosstalk

Nathalie Clément1,*, Marie Gueguen1,*, Martine Glorian1, Régis Blaise1,2, Marise Andréani1, Christel Brou2, Pedro Bausero1 and Isabelle Limon1,{ddagger}

1 UMR 7079 de Physiologie et Physiopathologie, Université Pierre et Marie Curie, CNRS, 7 quai Saint-Bernard, 75252 Paris, France
2 Unité de Signalisation Moléculaire et Activation Cellulaire, URA 2582, CNRS, Institut Pasteur, 75724 Paris Cedex 15, France


Figure 1
View larger version (23K):
[in this window]
[in a new window]

 
Fig. 1. Inhibition of {gamma}-secretase increases the positive effect of IL-1beta on the biosynthesis pathway of lipid mediators. Serum-starved cells were treated daily for 6, 24 or 48 hours with IL-1beta (10 ng/ml) or vehicle (control) and/or with DAPT (0.5 µM). (A) PLA2 secretion was expressed as a percentage of that of control cells (in pmol/min/µg RNA: 6.7±0.1 at 24 hours; 4.7±0.1 at 48 hours). (B) 15 µg of total proteins were separated by electrophoresis (6.5% SDS PAGE). COX-2 and beta-actin were immunodetected with appropriate antibodies. The autoradiogram is representative of three independent experiments. The histogram represents values obtained from scanning COX-2 bands normalized to that of beta-actin and results are expressed as a percentage of those from IL-1beta-treated cells. (C,D) PLA2-IIA (C) and COX-2 (D) transcripts were assayed by RT-PCR. Results are expressed as a percentage of the PLA2-IIA or COX-2 mRNA level of control cells and represent the mean ± s.e. of three independent experiments. (E) PGE2 secretion was expressed as a percentage of the basal PGE2 secretion of control cells (in pg/ml: 16.7±2.1 at 24 hours; 19.1±0.5 at 48 hours). For PLA2 and PGE2 assays, the data represent the mean ± s.e.m. of five or six independent experiments. C, control; IL, IL-1beta; D, DAPT; D+IL, DAPT plus IL-1beta versus IL-1beta; ns, non-significant; *, P<0.05; **, P<0.01; ***, P<0.001.

 

Figure 2
View larger version (66K):
[in this window]
[in a new window]

 
Fig. 2. Inhibition of {gamma}-secretase enhances the effect of IL-1beta on the contractile apparatus. Serum-starved cells were treated daily for 1 day (A) or 3 days (B,C) with IL-1beta (10 ng/ml) or vehicle (control) and/or with DAPT (0.5 µM). (A) {alpha}-Actin, SM-22, myocardin and calponin transcripts were assayed by RT-PCR. Results were expressed as a percentage of the mRNA level of control cells and represent the mean ± s.e.m. of three independent experiments. D+IL, DAPT plus IL-1beta versus IL-1beta. *, P<0.05; **, P<0.01. (B) Immunostaining of {alpha}-actin stress fibers was performed using a monoclonal antibody against {alpha}-actin and a secondary antibody coupled to FITC (green-stain, 20x or 63x). Cell nuclei were stained with Hoechst (blue). Images are representative of four independent experiments. (C) 15 µg of total proteins were separated by electrophoresis (10% SDS PAGE). {alpha}-Actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were immunodetected with appropriate antibodies. The autoradiogram is representative of three independent experiments. The histogram represents values obtained from scanning {alpha}-actin bands normalized to that of GAPDH and are expressed as a percentage of control cells. C, control; IL, IL-1beta; D, DAPT; D+IL, DAPT plus IL-1beta versus IL-1beta; **, P<0.01; ***, P<0.001; {dagger}, P<0.05.

 

Figure 3
View larger version (27K):
[in this window]
[in a new window]

 
Fig. 3. Effect of activated Notch on the prostanoid biosynthesis pathway and expression of {alpha}-actin. (A) Cells were treated for 48 hours with IL-1beta (10 ng/ml) or vehicle (control) and conditioned media collected from wild-type (WT CM) or Delta1-Fc-transfected ({Delta}1-Fc CM) confluent HEK 293 cells. The medium was assayed for secreted PLA2 and PGE2. Both parameters were expressed as a percentage of that of control cells (3.5±0.5 pmol/min/µg RNA and 27.9±8.7 pg/ml, respectively). The data represent the mean ± s.e.m. of three independent experiments. IL + {Delta}1-Fc CM, IL-1beta plus {Delta}1-Fc CM versus IL-1beta plus WT CM; *, P<0.05; **, P<0.01. (B) Cells were transfected with Notch3 intracellular domain (N3-ICD), Notch1 intracellular domain (N1-ICD) or empty (mock) plasmids and treated for 6, 24 or 48 hours with IL-1beta (10 ng/ml) and/or vehicle (control). The levels of PLA2 and PGE2 secretion were expressed as a percentage of those of control cells. The basal PLA2 secretion from mock-transfected cells was 7.3±0.3 and 4±1 pmol/min/µg RNA 24 and 48 hours after transfection, respectively. For N3-ICD-transfected cells, this parameter was 5.7±1.7 and 5.2±1.1 pmol/min/µg RNA and for N1-ICD-transfected cells, 4.8±0.8 and 5.1±1 pmol/min/µg RNA. The basal PGE2 secretion from mock-transfected cells was 18.2±0.6 pg/ml 48 hours after transfection. For N3-ICD- and N1-ICD-transfected cells, this parameter was 17.8±0.5 pg/ml. The data represent the mean ± s.e. of three to six independent experiments. PLA2-IIA transcripts were assayed by RT-PCR. The results are expressed as a percentage of the PLA2-IIA mRNA level of control cells and represent the mean ± s.e. of three independent experiments. *, P<0.05; **, P<0.01; ns, non-significant. (C) 15 µg of total proteins from mock, N3-ICD- or N1-ICD-transfected cells treated for 48 hours with IL-1beta (10 ng/ml) and/or vehicle (control) were separated by electrophoresis (10% SDS PAGE). {alpha}-Actin and GAPDH were immunodetected with appropriate antibodies. The autoradiogram is representative of three independent experiments. The histogram represents values obtained from scanning {alpha}-actin bands normalized to that of GAPDH and are expressed as a percentage of each control cell. C, control; IL, IL-1beta; *, P<0.05; ns, non-significant.

 

Figure 4
View larger version (17K):
[in this window]
[in a new window]

 
Fig. 4. Effect of the overexpression of the RBP-J{kappa} mutant on the prostanoid biosynthesis pathway. Cells were transfected with RBP-J{kappa} DN (a mutated form of RBP-J{kappa}) or empty (mock) plasmids and treated for 6, 24 or 48 hours with IL-1beta (10 ng/ml) or vehicle (control). (A) PLA2-IIA transcripts were assayed by RT-PCR. Results are expressed as a percentage of the PLA2-IIA mRNA level of control cells and represent the mean ± s.e.m. of three independent experiments. (B) Secretion of PLA2 and PGE2 was expressed as a percentage of that of control cells. The basal PLA2 secretion from mock-transfected cells was 3.6±0.9 and 4.1±0.6 pmol/min/µg RNA, 24 and 48 hours after transfection, respectively. For RBP-J{kappa} DN-transfected cells, this parameter was 4.9±0.7 and 4.5±0.8 pmol/min/µg RNA. The basal PGE2 secretion levels from mock and RBP-J{kappa}-DN-transfected cells were 16.9±1.5 and 18.3±0.9 pg/ml, respectively. The data represent the mean ± s.e.m. of four to five independent experiments. RBP-J{kappa} DN versus mock: *, P<0.05; **, P<0.01.

 

Figure 5
View larger version (23K):
[in this window]
[in a new window]

 
Fig. 5. Regulation of Notch-family gene expression in response to IL-1beta. (A) Serum-starved cells were treated for 6 hours with IL-1beta (10 ng/ml) or vehicle (control). Transcripts encoding Notch1, Notch3, Jagged1, Hes1, HRT1 and HRT2 were assayed by RT-PCR. Results are expressed as the mRNA level in IL-1beta-treated cells normalized to that of control cells. Values represent the mean ± s.e.m. of three independent experiments and were compared with the baseline. (B) Cells were transfected with I{kappa}B{alpha}32-36 (a mutated form of I{kappa}B{alpha}) or empty (mock) plasmids and treated for 6 hours with IL-1beta (10 ng/ml) or vehicle (control). Results are expressed as a percentage of the mRNA level in control cells and represent the mean ± s.e.m. of three independent experiments. Values of the mRNA expression from IL-1beta-treated I{kappa}B{alpha}32-36-transfected cells were compared with those of IL-1beta-treated mock-transfected cells. C, control; IL, IL-1beta; *, P<0.05; **, P<0.01; ***, P<0.001; ns, non-significant. Results are expressed as the mean ± s.e. of at least four independent experiments.

 

Figure 6
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 6. Effect of the overexpression of Notch1 or Notch3 intracellular domains on I{kappa}B{alpha} expression. Cells were transfected with N3-ICD, N1-ICD or empty (mock) plasmids and treated for 6 hours with IL-1beta (10 ng/ml) or vehicle (control). I{kappa}B{alpha} transcripts were assayed by RT-PCR. Results are expressed as a percentage of the I{kappa}B{alpha} mRNA level from control cells and represent the mean ± s.e.m. of three independent experiments. C, control; IL, IL-1beta; *, P<0.05; ** P<0.01.

 

Figure 7
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 7. Putative model for Notch and IL-1beta crosstalk to regulate vascular smooth muscle inflammation and differentiation. See Discussion for details. HDAC, histone deacetylase complex; N-CoR, nuclear co-repressor receptor.

 





© The Company of Biologists Ltd 2007